Madrigal Pharmaceuticals, Inc. Share Price Today: Live Updates & Key Insights

Madrigal Pharmaceuticals, Inc. share price today is $442.5, up -2.88%. The stock opened at $455.48 against the previous close of $454.22, with an intraday high of $462.89 and low of $439.88.

Madrigal Pharmaceuticals, Inc. Share Price Chart

Madrigal Pharmaceuticals, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Madrigal Pharmaceuticals, Inc. Share Price Performance

$442.5 -0.0288(-2.88%) MDGL at 23 Mar 2026 02:14 PM Biotechnology
Lowest Today 439.88
Highest Today 462.89
Today’s Open 455.48
Prev. Close 454.22
52 Week High 615.00
52 Week Low 265.00
Day’s Range: Low 439.88 High 462.89
52-Week Range: Low 265.00 High 615.00
1 day return -
1 Week return +0.11
1 month return +0.54
3 month return -26.82
6 month return +0.26
1 year return +27.31
3 year return +90.02
5 year return +266.71
10 year return -

Madrigal Pharmaceuticals, Inc. Institutional Holdings

Baker Bros Advisors LP 9.34

RTW INVESTMENTS, LLC 8.69

HHG PLC 8.03

Vanguard Group Inc 7.89

venBio Select Advisor LLC 7.88

Paulson & Company Inc 7.44

BlackRock Inc 6.80

State Street Corp 2.87

Vanguard Total Stock Mkt Idx Inv 2.51

Wellington Management Company LLP 2.01

iShares Russell 2000 ETF 1.97

Geode Capital Management, LLC 1.97

FMR Inc 1.92

Janus Concentrated Growth CF 1.87

Janus Henderson Forty S 1.87

Vanguard Small Cap Index 1.79

The Goldman Sachs Group Inc 1.68

William Blair Investment Management, LLC 1.54

T. Rowe Price Associates, Inc. 1.54

Amvescap Plc. 1.31

Polar Capital Holdings PLC 1.18

Armistice Capital, LLC 1.16

Polar Capital Biotech S Inc 1.11

Morgan Stanley - Brokerage Accounts 1.09

Hood River Capital Management LLC 1.08

Lord, Abbett & Co LLC 1.07

Vanguard Health Care Inv 1.05

RTW Biotech Opportunities Ord 0.93

Vanguard Institutional Extnd Mkt Idx Tr 0.88

Janus Henderson Contrarian D 0.84

Janus Henderson US Opportunistic Alpha 0.84

Fidelity Small Cap Index 0.79

State Street® SPDR® S&P® Biotech ETF 0.77

iShares Russell 2000 Growth ETF 0.68

iShares Biotechnology ETF 0.67

Hood River Small-Cap Growth Instl 0.59

Vanguard Small Cap Value Index Inv 0.58

Janus Henderson Global Life Sciences 0.57

Janus Henderson Global Life Sciences D 0.57

American Century U.S. Small Cap Growth 0.57

Madrigal Pharmaceuticals, Inc. Market Status

Strong Buy: 10

Buy: 3

Hold: 1

Sell: 1

Strong Sell: 0

Madrigal Pharmaceuticals, Inc. Fundamentals

Market Cap 10120.20 M

PB Ratio 16.7917

PE Ratio 0.0

Enterprise Value 9484.27 M

Total Assets 1259.59 M

Volume 574111

Madrigal Pharmaceuticals, Inc. Company Financials

Annual Revenue FY25:958403000 958.4M, FY24:180133000 180.1M, FY23:0 0.0M, FY22:0 0.0M, FY21:37318 0.0M

Annual Profit FY25:902255000 902.3M, FY24:173900000 173.9M, FY23:-527000 -0.5M, FY22:null 0.0M, FY21:273000 0.3M

Annual Net worth FY25:-288284000 -288.3M, FY24:-465892000 -465.9M, FY23:-373630000 -373.6M, FY22:-299314000 -299.3M, FY21:-241078000 -241.1M

Quarterly Revenue Q4/2025:321083000 321.1M, Q3/2025:287268000 287.3M, Q2/2025:212802000 212.8M, Q1/2025:137250000 137.3M, Q3/2024:62175000 62.2M

Quarterly Profit Q4/2025:296635000 296.6M, Q3/2025:269146000 269.1M, Q2/2025:203737000 203.7M, Q1/2025:132737000 132.7M, Q3/2024:60023000 60.0M

Quarterly Net worth Q4/2025:-58575000 -58.6M, Q3/2025:-114190000 -114.2M, Q2/2025:-42281000 -42.3M, Q1/2025:-73238000 -73.2M, Q3/2024:-106964000 -107.0M

About Madrigal Pharmaceuticals, Inc. & investment objective

Company Information Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

Organisation Biotechnology

Employees 915

Industry Biotechnology

CEO Mr. William J. Sibold

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Madrigal Pharmaceuticals, Inc. FAQs

What is the share price of Madrigal Pharmaceuticals, Inc. today?

The current share price of Madrigal Pharmaceuticals, Inc. is $442.5.

Can I buy Madrigal Pharmaceuticals, Inc. shares in India?

Yes, Indian investors can buy Madrigal Pharmaceuticals, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Madrigal Pharmaceuticals, Inc. shares in India?

You can easily invest in Madrigal Pharmaceuticals, Inc. shares from India by:

Can I buy fractional shares of Madrigal Pharmaceuticals, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. has a market cap of $10120.20 M.

In which sector does Madrigal Pharmaceuticals, Inc. belong?

Madrigal Pharmaceuticals, Inc. operates in the Biotechnology sector.

What documents are required to invest in Madrigal Pharmaceuticals, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Madrigal Pharmaceuticals, Inc.?

The PE ratio of Madrigal Pharmaceuticals, Inc. is N/A and the PB ratio is 16.79.